XERIS PHARMACEUTICALS INC - FORM S-1 - EX-23.1 - May 24, 2018

Attached files

file filename
EX-10.17 - EX-10.17 - XERIS PHARMACEUTICALS INCd547651dex1017.htm
EX-10.16 - EX-10.16 - XERIS PHARMACEUTICALS INCd547651dex1016.htm
EX-10.15 - EX-10.15 - XERIS PHARMACEUTICALS INCd547651dex1015.htm
EX-10.14 - EX-10.14 - XERIS PHARMACEUTICALS INCd547651dex1014.htm
EX-10.13 - EX-10.13 - XERIS PHARMACEUTICALS INCd547651dex1013.htm
EX-10.12 - EX-10.12 - XERIS PHARMACEUTICALS INCd547651dex1012.htm
EX-10.6 - EX-10.6 - XERIS PHARMACEUTICALS INCd547651dex106.htm
EX-10.5 - EX-10.5 - XERIS PHARMACEUTICALS INCd547651dex105.htm
EX-10.4 - EX-10.4 - XERIS PHARMACEUTICALS INCd547651dex104.htm
EX-10.3 - EX-10.3 - XERIS PHARMACEUTICALS INCd547651dex103.htm
EX-10.1 - EX-10.1 - XERIS PHARMACEUTICALS INCd547651dex101.htm
EX-4.1 - EX-4.1 - XERIS PHARMACEUTICALS INCd547651dex41.htm
EX-3.5 - EX-3.5 - XERIS PHARMACEUTICALS INCd547651dex35.htm
EX-3.4 - EX-3.4 - XERIS PHARMACEUTICALS INCd547651dex34.htm
EX-3.3 - EX-3.3 - XERIS PHARMACEUTICALS INCd547651dex33.htm
EX-3.1 - EX-3.1 - XERIS PHARMACEUTICALS INCd547651dex31.htm
S-1 - S-1 - XERIS PHARMACEUTICALS INCd547651ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Xeris Pharmaceuticals, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Chicago, Illinois

May 24, 2018

XERIS PHARMACEUTICALS INC Reports